Paxman AB (publ) (STO:PAX)

Market Cap	1.42B
Revenue (ttm)	263.20M
Net Income (ttm)	40.20M
Shares Out	19.01M
EPS (ttm)	2.11
PE Ratio	35.45
Forward PE	22.00
Dividend	n/a
Ex-Dividend Date	n/a

Volume	30,138
Average Volume	62,484
Open	77.60
Previous Close	77.60
Day's Range	73.40 - 78.40
52-Week Range	34.00 - 79.00
Beta	0.68
RSI	62.89
Earnings Date	Apr 25, 2025

About Paxman AB

Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various cancer centers and hospitals. The company has a research collaboration agreement with National University Hospital, Singapore for the development of portable cooling and compression device. Paxman AB (publ) was founded in 1996 and is based in Karlshamn, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1996
• Employees: 105
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: PAX

Financial Performance

In 2024, Paxman AB's revenue was 263.20 million, an increase of 19.30% compared to the previous year's 220.61 million. Earnings were 40.20 million, an increase of 382.55%.